Main Menu

Clinical PhD Fellowships

Our clinical PhD fellowships are provided to develop and support future leaders in clinical cancer research.

About our clinical PhD fellowships

Our clinical PhD fellowships are provided to develop and support future leaders in clinical cancer research. The CRUK Clinical Academic Training Programme – ICR-Imperial is a programme which will provide clinical academics with the expertise to discover, develop, and deliver the next generation of treatments, technologies, and methodologies into clinical care.

The fellowship awards include tuition fees, research expenses, and a clinical salary. Applicants from a range of clinical specialities are invited to apply, including oncology, paediatrics, radiology, surgery, anaesthesia, and haematology.

Current opportunities

We are advertising a range of projects for up to six fellowships. You can read the project proposals below, and follow the links for more information. If the opportunities below don't interest you, you can sign up to our mailing list for future opportunities.

 


Available projects and the project archive

You can view our current and past projects, below. Use the dropdowns to select the subject you are interested in, and then click 'Filter' to see relevant projects. If you use a filter and cannot see any results, then there are no projects matching your requirements.

Clinical specialty:

Primary institution:

Deadline:

 

Identification of novel tissue and circulating biomarkers of anti-tumoral immune response and identification of novel drug targets in locally-advanced head and neck squamous cell carcinoma (LA-HNSCC)

  • Primary supervisor: Dr Shreerang Bhide (ICR)
  • Primary Division: Radiotherapy and Imaging
  • Primary team: Targeted therapy

Project summary

Targeting inflammatory cell mediated fuelling of prostate cancer

  • Primary supervisor: Johann de Bono (ICR)
  • Primary Division: Clinical Studies
  • Primary team: Prostate Cancer Targeted Therapy Group

Project summary

Decreasing the burden of cancer (early detection in high risk groups with a genetic predisposition and identification of new methods of screening)

  • Primary supervisor: Ros Eeles (ICR)
  • Primary Division: Genetics and Epidemiology
  • Primary team: Oncogenetics

Project summary

ctDNA guided optimisation of chemotherapy in colorectal cancer using evolutionary genomics

  • Primary supervisor: Trevor Graham (ICR)
  • Primary Division: Molecular Pathology/Centre for Cancer Evolution
  • Primary team: Genomics and Evolutionary Dynamics

Project summary

Lung cancer early detection: novel liquid biopsy technologies with a metabolomics focus

  • Primary supervisor: Richard Lee (ICR)
  • Primary Division: Genetics and Epidemiology
  • Primary team: Early Diagnosis and Detection Team

Project summary

Bone marrow microenvironment remodelling and innate immunity signalling pathways in acute myeloid leukaemia patient responses

  • Primary supervisor: Cristina Lo Celso (Imperial)
  • Primary Faculty: Natural Sciences
  • Primary Department: Life Sciences/Immunology and Inflammation

Project summary

Molecular and imaging biomarkers for prostate cancer 

  • Primary supervisor: Stephen Mangar (Imperial)
  • Primary Faculty: Medicine
  • Primary Department: Radiotherapy

Project summary

Super-resolution imaging to assess epigenetic evolution in ovarian high grade serous carcinoma

  • Primary supervisor: Iain McNeish (Imperial)
  • Primary Faculty: Medicine
  • Primary Department: Surgery and Cancer

Project summary

Investigating and targeting the sub-clonal dynamics of therapy resistance in metastatic invasive lobular breast cancer

  • Primary supervisor: Rachael Natrajan (ICR)
  • Primary Division: Breast Cancer
  • Primary team: Functional Genomics

Project summary

Drivers of metastasis and recurrence in head and neck and gynaecological squamous cell carcinomas

  • Primary supervisor: Ben O'Leary (ICR)
  • Primary Division: Radiotherapy and Imaging/Centre for Cancer Evolution
  • Primary team: Targeted Therapy

Project summary

Development of a disruptive artificial intelligence-based multi-modal companion diagnosis for precise combination cancer immunotherapies

  • Primary supervisor: Anguraj Sadanandam (ICR)
  • Primary Division: Molecular Pathology
  • Primary team: Systems and Precision Cancer Medicine

Project summary

Improving patient outcomes by circumventing treatment resistance in lethal prostate cancer

  • Primary supervisor: Adam Sharp (ICR)
  • Primary Division: Clinical Studies
  • Primary team: Translational Therapeutics Team

Project summary

The development of novel fluorescence and radiolabelled markers in gastrointestinal stromal tumour (GIST) and evaluation of their use perioperative assessment and fluorescence guided surgery

  • Primary supervisor: Myles Smith (ICR)
  • Primary Division: Radiotherapy and Imaging/Academic Surgery
  • Primary team: Melanoma and Rare Tumour Surgery Team

Project summary

Harnessing the immunogenic potential of radiotherapy for maximum impact in high-risk hormone positive breast cancer patients – translational research linked to neo-adjuvant radiotherapy trials

  • Primary supervisor: Navita Somaiah (ICR)
  • Primary Division: Radiotherapy and Imaging
  • Primary team: Translational Breast Radiobiology

Project summary

Incorporating uncertainty information into artificial intelligence auto-contouring approaches for radiotherapy planning

  • Primary supervisor: Alexandra Taylor (ICR)
  • Primary Division: Radiotherapy and Imaging
  • Primary team: Radiotherapy for Gynaecological Cancer

Project summary

Developing a miniaturised robotics platform with integrated real-time metabolomics for first-in-human enhanced minimally invasive surgery in head and neck cancer

  • Primary supervisor: Burak Temelkuran (Imperial)
  • Primary Faculty: Medicine
  • Primary Department: Metabolism, Digestion and Reproduction

Project summary

Massive germline exome sequencing to identify novel breast cancer susceptibility genes

  • Primary supervisor: Clare Turnbull (ICR)
  • Primary Division: Genetics and Epidemiology
  • Primary team: Translational Genetics

Project summary

Analysing gene expression changes with liquid biopsies to identify mechanisms of resistance to breast cancer treatment

  • Primary supervisor: Nicholas Turner (ICR)
  • Primary Division: Breast Cancer
  • Primary team: Molecular Oncology

Project summary

Using argumentation-based eXplainable AI to integrate large, shallow and small detailed datasets in palliative radiotherapy

  • Primary supervisor: Matt Williams (Imperial)
  • Primary Division: Surgery and Cancer
  • Primary team: Cancer

Project summary

Discovering novel immunogenic peptides induced by aberrant splicing in breast cancer

  • Primary supervisor: Luis Zapata (ICR)
  • Primary Division: Molecular Pathology
  • Primary team :Evolutionary Genomics and Modelling

Project summary


Previous projects 

PhD studentships

Applications for our main PhD studentships recruitment round are closed.

ICR values

Our values – developed together as an organisation – make it clear how each and every one of us work to meet our mission – to make the discoveries that defeat cancer.